reaching agreement about future actions
DOI: Published online: February 24, 2021 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Young Min Cho
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Tirzepatide also acts on the GIP receptor, potentially providing greater benefits for blood sugar control and weight reduction compared to Ozempic
NACHT Leucine-rich repeat protein 1 recognize pathogen-associated molecular patterns and DAMPs and recruit other proteins to form signaling complexes that promote inflammation or type I interferon production (Jin et al., 2007
Its dual-receptor mechanism has generated significant academic interest, with research examining its distinct signalling properties compared to single-receptor GLP-1 agonists in pancreatic, adipose, and hypothalamic tissue contexts